dihydroxyphenylalanine has been researched along with Cerebral Palsy in 6 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Cerebral Palsy: A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Strategies in treatment of movement disorders are discussed with the illustration of three patients with dystonia." | 1.33 | Treatment strategies in movement disorders. ( Speelman, JD, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Speelman, JD | 1 |
| Papeschi, R | 1 |
| Molina-Negro, P | 1 |
| Sourkes, TL | 1 |
| Erba, G | 1 |
| Papavasiliou, PS | 1 |
| Cotzias, GC | 1 |
| Düby, SE | 1 |
| Steck, AJ | 1 |
| Fehling, C | 1 |
| Bell, MA | 1 |
| Rosenthal, RK | 1 |
| McDowell, FH | 1 |
| Cooper, W | 1 |
| Chyatte, SB | 1 |
| Birdsong, JH | 1 |
| Mrozek, K | 1 |
| Kamińska, A | 1 |
| Marciniak, M | 1 |
2 trials available for dihydroxyphenylalanine and Cerebral Palsy
| Article | Year |
|---|---|
Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.
Topics: Administration, Oral; Adult; Biotransformation; Brain; Carbon Monoxide Poisoning; Cerebral Palsy; Ch | 1972 |
Levodopa therapy in athetoid cerebral palsy. A preliminary report.
Topics: Activities of Daily Living; Adolescent; Adult; Cerebral Palsy; Clinical Trials as Topic; Dihydroxyph | 1972 |
4 other studies available for dihydroxyphenylalanine and Cerebral Palsy
| Article | Year |
|---|---|
Treatment strategies in movement disorders.
Topics: Adult; Botulinum Toxins; Cerebral Palsy; Dihydroxyphenylalanine; Dopamine Agents; Dystonia; Female; | 2005 |
The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Cerebral Palsy; Cerebral Ventricles; Diazepam; Dihydroxyp | 1972 |
Methods-time measurement in assessment of motor performance.
Topics: Central Nervous System Diseases; Cerebral Palsy; Dihydroxyphenylalanine; Hemiplegia; Humans; Methods | 1972 |
[Attempt at Larodopa and Viregyt treatment in a case of progressive supranuclear palsy].
Topics: Amantadine; Cerebral Palsy; Dihydroxyphenylalanine; Drug Synergism; Female; Humans; Middle Aged | 1972 |